ArticleCurrent pharmaceutical biotechnology2024

miR-488-3p Represses Malignant Behaviors and Facilitates Autophagy of Osteosarcoma Cells by Targeting Neurensin-2.

Chao Yun et al.PubMed ↗Publisher ↗

No numbers read from the abstract.